What Is This Weird CVR in My Brokerage Account? How to Find Out What It’s Worth

Every so often, a brokerage account acquires something that looks less like an investment and more like a clerical error.

Instead of a company name and ticker, you may see something like:

• 007CVR020
• 550CVR021
• CONTRA AEGLEA BIOTHERA
• or some other cryptic string ending in CVR

The market value may be $0.00. There may be no quote. Clicking on it may tell you almost nothing.

And yet the position can represent a perfectly real legal right to future money.

If you already know what a contingent value right is, the mystery is usually more practical: What is this particular thing in my account, where did it come from, and does it have any value?

That is what this article is about.

For the broader explanation of how these securities work, start with CVRs Explained: The Weird Portfolio Zombies That Might Still Pay.

Quick Answer: What Is That CVR Code?

A CVR in your brokerage account is usually a contingent value right you received because you owned stock in a company that was acquired, reorganized or otherwise transformed.

The old stock may be gone. The CVR remains because former shareholders retained a contractual right to receive money if certain conditions are met.

Those conditions might include:

• a drug receiving regulatory approval;
• a product reaching a sales target;
• a legacy asset being sold;
• a licensing deal being signed;
• or proceeds being distributed from assets left behind in a transaction.

The strange code in your account is often how your broker or its securities-processing system identifies that right when there is no ordinary ticker symbol.

Your broker may know enough to keep the position in your account while knowing almost nothing useful about how to display it.

Why Does It Show $0.00?

Usually because there is no public market from which your broker can obtain a price.

Many CVRs are expressly non-transferable. They do not trade on Nasdaq, the NYSE or the OTC market. There is no bid, no ask and no last sale for the brokerage system to display.

So the system prints $0.00.

That number can mean several very different things:

• the CVR really is unlikely ever to pay;
• the right is still alive but impossible to value;
• a milestone remains years away;
• a payment has been earned but has not yet been distributed;
• or the CVR has an economically meaningful future payment that simply has no market price.

This is a recurring problem in the portfolio graveyard: a brokerage statement compresses several very different kinds of uncertainty into the same neat number.

Example: What Is 007CVR020?

One particularly good example is the CVR associated with Aeglea BioTherapeutics, which later became Spyre Therapeutics.

In 2023, Aeglea acquired the privately held Spyre Therapeutics and radically changed the public company. A non-transferable CVR was distributed to legacy Aeglea shareholders of record as of July 3, 2023.

The CVR gave those old shareholders rights to proceeds from monetizing Aeglea’s legacy assets.

That history explains why someone can open a brokerage account years later and encounter a line identified as 007CVR020 or Aeglea/Spyre CVR even though Aeglea itself no longer exists under that name.

And this is a particularly good lesson in why a displayed value of zero should not be treated as definitive.

In its quarterly report for June 30, 2026, Spyre reported that all of the contingencies related to the legacy CVR had been resolved.

The company reported:

• $22.933 million of payments to CVR holders during the first six months of 2026; and
• a remaining $38.620 million CVR liability as of June 30, 2026.

In other words, an obscure position that can look like an unpriced relic in a brokerage account corresponds to a company liability measured in the tens of millions of dollars.

The brokerage screen is not an appraisal.

Example: What Is 550CVR021?

Another code that appears in brokerage accounts is 550CVR021, associated with the 2024 acquisition of Lumos Pharma by Double Point Ventures.

Lumos shareholders received $4.25 per share in cash plus one non-transferable CVR for each share.

The tender-offer documents describe several possible payments, including revenue milestones tied to LUM-201 through the end of 2037.

Those include:

• $1.00 per CVR after the first $500 million annual global revenue milestone;
• $1.50 after the $1 billion milestone;
• $2.00 after the $1.5 billion milestone;
• plus certain potential payments tied to transactions involving Lumos assets.

There is no useful daily stock price for this right because it is not an ordinary publicly traded security.

Its economic value depends on whether the events specified in the CVR agreement actually happen.

How to Identify a Mystery CVR in Your Account

If an unfamiliar CVR appears in Fidelity, Schwab or another brokerage account, I would work through it in this order.

1. Copy the Exact Code

Do not begin with the abbreviated company description. Copy the entire identifier exactly as your broker displays it.

If it says:

550CVR021

search for that exact string in quotation marks.

Odd securities leave surprisingly good documentary fingerprints because institutional funds, corporate filings and other financial records often retain the same identifiers.

2. Identify the Company That Created It

You are trying to connect the code to an original corporate transaction.

Search combinations such as:

• “550CVR021”
• “550CVR021” Lumos
• “Lumos Pharma” CVR agreement
• “Aeglea” contingent value rights

Once you have the issuer, the search becomes much easier.

3. Find the Original CVR Agreement

The most useful document is usually the actual Contingent Value Rights Agreement.

For public companies, it is often filed with the SEC as an exhibit to a merger agreement, tender offer or Form 8-K.

That agreement should tell you:

• who was entitled to receive the CVR;
• what event triggers payment;
• how payments are calculated;
• how long the rights remain outstanding;
• whether the CVR can be transferred;
• who acts as the rights agent;
• and what happens when the CVR terminates.

This document is considerably more useful than staring at the $0.00 quote in your brokerage account and hoping it develops explanatory powers.

4. Find the Latest Filing, Not Just the Original Deal Announcement

The original merger announcement tells you what could happen.

You also need to know what did happen.

Search the surviving company’s recent SEC filings for:

• CVR
• contingent value right
• CVR liability
• milestone
• rights agent

You may find disclosures showing:

• milestones achieved;
• milestones missed;
• asset sales;
• cash received;
• payments already made;
• or an estimated liability for future distributions.

The current Spyre filing is a good example. You can learn far more from its CVR-liability footnote than from the brokerage-account description.

5. Check the Expiration Date Carefully

CVRs do not necessarily live forever.

Some terminate after a few years. Others can remain relevant for more than a decade.

The Lumos revenue milestones, for example, can run through 2037.

A security that has been sitting untouched in your account for two years may still be early in its contractual life.

Can You Sell a CVR?

Sometimes, but many of the CVRs that create these mysterious brokerage positions cannot be sold at all.

The Aeglea and Lumos rights discussed above were issued as non-transferable CVRs.

The specific agreement controls. Some agreements allow narrow exceptions for transfers through inheritance, estate planning or operation of law while prohibiting ordinary sales.

If your CVR has no market quote and your broker provides no trade button, that may be exactly how the security was designed.

If I Can’t Sell It, How Do I Get Paid?

Usually you do nothing.

If a payment becomes due, the rights agent and the financial intermediaries handling the security process the distribution to eligible holders.

For a CVR held through a brokerage account, the payment would generally work its way through the securities-processing chain and arrive in the account associated with the right.

This is one reason I would be cautious about trying to make an unfamiliar CVR disappear simply because the brokerage statement says $0.00.

First identify what it is.

What If the Company Name No Longer Exists?

This is common.

CVRs tend to emerge from corporate transactions, which are also very good at making company names disappear.

You might begin with:

Aeglea BioTherapeutics

and end up needing to search filings from:

Spyre Therapeutics

The key is to follow the corporate chain forward from the transaction that created the CVR.

Do not assume the lack of a current company under the old name means the right vanished with it.

What If My Broker Has No Idea What It Is?

This is not especially surprising.

Customer-service representatives are equipped to answer questions about ordinary securities. An obscure, non-transferable CVR from a biotech acquisition three years ago is a more specialized request.

Ask specific operational questions:

• What is the full security identifier?
• What issuer name is attached to the position?
• Is the position marked transferable or non-transferable?
• Has the broker received any recent distributions?
• Does the position have a rights agent or corporate-actions record attached to it?

You are much more likely to get useful information than if you simply ask, “What is this thing?”

When Is a CVR Actually Worthless?

Eventually, some really do die.

A CVR may become worthless because:

• the contractual deadline passed;
• the required drug approval never occurred;
• a sales milestone was never reached;
• the underlying asset was abandoned;
• the agreement terminated;
• or every possible payout condition has been resolved at zero.

At that point, the brokerage account may still retain a placeholder for some time.

That problem overlaps with the broader world of zombie CUSIPs and other stranded securities.

If you eventually determine that a holding really is dead and simply want it out of your account, see our guide to getting worthless stock out of a brokerage account.

Do Not Ignore the Tax Records

CVR payments can also create tax-reporting issues, and the treatment can depend on how the original transaction and subsequent payment are structured.

Keep:

• the original merger or acquisition documents;
• the CVR agreement;
• brokerage statements showing the position;
• records of any cash distributions;
• and any tax forms or notices you receive.

If the amounts are significant or the tax treatment is unclear, this is a reasonable place to involve a tax professional rather than reverse-engineer the answer from a brokerage statement.

The Brokerage Account Is the Beginning of the Investigation

A mysterious CVR line item usually looks less mysterious once you trace it back to the transaction that created it.

The process is fairly mechanical:

1. copy the exact identifier;
2. identify the original company;
3. find the transaction;
4. read the CVR agreement;
5. check the latest filings;
6. identify the milestones and expiration date;
7. and determine whether any payments remain possible.

The hardest part is often the first step: realizing that the meaningless-looking code at the bottom of your account is something worth investigating.

Sometimes the answer will be disappointing.

Sometimes the answer will be that the position could remain there for another decade.

And occasionally, as the Aeglea/Spyre example demonstrates, the ugly little $0.00 line item is attached to actual cash that is still making its way to shareholders.

Which is why I have learned to be suspicious of anything in a brokerage account that looks completely worthless but refuses to leave.